Plain-English translation of NCT07112599 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers are testing a new artificial intelligence tool designed to predict whether high-risk prostate cancer has spread to lymph nodes — the small bean-shaped organs that filter cancer cells. The tool analyzes MRI scans and tissue samples taken after surgery to learn whether it can accurately spot which patients have lymph node involvement. If successful, this AI prediction tool could help doctors plan more precise, personalized treatment for men with aggressive prostate cancer.
Currently, doctors struggle to know in advance which men with high-risk prostate cancer will have cancer spread to their lymph nodes. This uncertainty makes it harder to plan the right treatment. By training an AI tool on real patient images and tissue data, researchers hope to give doctors a more accurate way to predict this spread before or during surgery, leading to better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will undergo an MRI scan of your pelvis before your prostate biopsy, and pathology slides will be scanned after your prostate surgery. Experienced radiologists and pathologists will outline the tumor areas on these images, which are then fed into the AI model to predict whether cancer has spread to your lymph nodes. Your actual surgical findings (whether lymph nodes are involved) will be compared to the AI's predictions to test how accurate the tool is. The study involves 2,000 men across five major Chinese hospitals.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China